Cargando…

Circulating Myeloid‐Related Protein–8/14 is Related to Thromboxane‐Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low‐Dose Aspirin Treatment

BACKGROUND: Platelet activation is involved in acute coronary syndromes (ACS). Incomplete suppression by low‐dose aspirin treatment of thromboxane (TX) metabolite excretion (urinary 11‐dehydro‐TXB(2)) is predictive of vascular events in high‐risk patients. Myeloid‐related protein (MRP)‐8/14 is a het...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santilli, Francesca, Paloscia, Leonardo, Liani, Rossella, Di Nicola, Marta, Di Marco, Massimo, Lattanzio, Stefano, La Barba, Sara, Pascale, Silvia, Mascellanti, Marco, Davì, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310373/ https://www.ncbi.nlm.nih.gov/pubmed/25037196 http://dx.doi.org/10.1161/JAHA.114.000903

Ejemplares similares

Circulating Dickkopf‐1 in Diabetes Mellitus: Association With Platelet Activation and Effects of Improved Metabolic Control and Low‐Dose Aspirin
por: Lattanzio, Stefano, et al.
Publicado: (2014)

Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss †
por: Simeone, Paola, et al.
Publicado: (2018)

Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia
por: Tosetto, Alberto, et al.
Publicado: (2021)

Effects of Aspirin and Prednisone on Platelet Function and Thromboxane Synthesis in Healthy Dogs
por: Thomason, John M., et al.
Publicado: (2019)

Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A(2)
por: Lucotti, Serena, et al.
Publicado: (2019)

Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation
por: Petrucci, Giovanna, et al.
Publicado: (2022)

Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial
por: Joharatnam-Hogan, Nalinie, et al.
Publicado: (2023)

Unexplained Cardiac Arrest After Near Drowning in a Young Experienced Swimmer: Insight from Cardiovascular Magnetic Resonance Imaging
por: Mantini, Cesare, et al.
Publicado: (2016)

Thromboxane generation by human monocytes enhances platelet function
Publicado: (1986)

Platelet Dysfunction in Type 1 Diabetes: Stressing the Thromboxanes
por: Wisinski, Jaclyn A., et al.
Publicado: (2016)

Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen
por: Simeone, Paola, et al.
Publicado: (2022)

Urine 11-Dehydro-Thromboxane B2 in Aspirin-Naive Males with Metabolic Syndrome
por: Piechota, Wiesław, et al.
Publicado: (2022)

LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro
por: Halvorsen, Bente, et al.
Publicado: (2016)

High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets
por: Russo, Isabella, et al.
Publicado: (2012)

Human platelet-mediated cytotoxicity against Toxoplasma gondii: role of thromboxane
Publicado: (1991)

Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets
por: Raz, Limor, et al.
Publicado: (2014)

Comparative effects of immediate‐release and extended‐release aspirin on basal and bradykinin‐stimulated excretion of thromboxane and prostacyclin metabolites
por: Gamboa, Jorge L., et al.
Publicado: (2016)

Human Thromboxane A(2) Receptor Genetic Variants: In Silico, In Vitro and “In Platelet” Analysis
por: Gleim, Scott, et al.
Publicado: (2013)

Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project
por: Raparelli, V., et al.
Publicado: (2022)

Glucagon-Like Peptide-1 Receptor Regulates Thromboxane-Induced Human Platelet Activation
por: Cahill, Katherine N., et al.
Publicado: (2022)

Study of pulsed electrostatic field (PESF) in the perfusion of peripheral tissues: Microangiopathy, nutrition and quality of perceiver life
por: Liani, Rossella, et al.
Publicado: (2022)

The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting
por: De Stefano, Valerio, et al.
Publicado: (2018)

Thromboxane Modulates Endothelial Permeability
por: Klausner, J. M., et al.
Publicado: (1994)

Stability of thromboxane in blood samples
por: Helgadóttir, Helga, et al.
Publicado: (2019)

Correction: Human Thromboxane A(2) Receptor Genetic Variants: In Silico, In Vitro and “In Platelet” Analysis
por: Gleim, Scott, et al.
Publicado: (2013)

Phosphorylation of protein kinase Cδ Tyr311 positively regulates thromboxane generation in platelets
por: Kostyak, John C., et al.
Publicado: (2021)

Age-related increase of thromboxane B(2) and risk of cardiovascular disease in atrial fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016)

Calcium-Dependent Src Phosphorylation and Reactive Oxygen Species Generation Are Implicated in the Activation of Human Platelet Induced by Thromboxane A2 Analogs
por: Minuz, Pietro, et al.
Publicado: (2018)

Sex-Specific Association of Endogenous PCSK9 With Memory Function in Elderly Subjects at High Cardiovascular Risk
por: Simeone, Paola G., et al.
Publicado: (2021)

Endogenous PCSK9 may influence circulating CD45(neg)/CD34(bright) and CD45(neg)/CD34(bright)/CD146(neg) cells in patients with type 2 diabetes mellitus
por: Tripaldi, Romina, et al.
Publicado: (2021)

Platelet Isoprostane Overproduction in Diabetic Patients Treated With Aspirin
por: Cangemi, Roberto, et al.
Publicado: (2012)

Platelets, Aspirin and Cardiovascular Disease
por: Elwood, P. C.
Publicado: (1976)

Fifty years with aspirin and platelets
por: Patrono, Carlo
Publicado: (2022)

Measurement of Thromboxane Biosynthesis in Health and Disease
por: Patrono, Carlo, et al.
Publicado: (2019)

Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer
por: Watkins, Gareth, et al.
Publicado: (2005)

Derrone Inhibits Platelet Aggregation, Granule Secretion, Thromboxane A(2) Generation, and Clot Retraction: An In Vitro Study
por: Shin, Jung-Hae, et al.
Publicado: (2021)

Mentalization, attachment, and subjective identity
por: Guerini, Rossella, et al.
Publicado: (2015)

Foetal vascular responses to thromboxane receptor blockade
por: Meyer, B. A., et al.
Publicado: (1992)

Prostacyclin and thromboxane in benign and malignant breast tumours.
por: Laekeman, G. M., et al.
Publicado: (1986)

Factors Associated with Aspirin Resistance in Hong Kong Chinese Patients with Stable Coronary Heart Disease Using the Multiplate(®) Analyzer and Serum Thromboxane B(2)
por: Zeng, Weiwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6rt2buujhrh4bmulhvmponnasc